603259:SHA
WuXi AppTec Co Ltd
CNÂ¥151.24
arrow_downward
-2.11%(-3.26) 1D
Sep 11, 3:00:02 PM GMT+8 · CNY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 603259...
Open
CNÂ¥154.00
High
CNÂ¥154.36
Low
CNÂ¥149.70
Mkt. cap
468.75B
Avg. vol.
58.24M
Volume
30.36M
Dividend
1.38%
Quarterly dividend
CNÂ¥0.52
Ex-dividend date
May 29, 2026
P/E ratio
20.58
52-wk high
CNÂ¥173.60
52-wk low
CNÂ¥87.09
EPS
CNÂ¥7.35
Shares outstanding
1.05B
No. of employees
36K
Open
CNÂ¥154.00
High
CNÂ¥154.36
Low
CNÂ¥149.70
Mkt. cap
468.75B
Avg. vol.
58.24M
Volume
30.36M
Dividend
1.38%
Quarterly dividend
CNÂ¥0.52
Ex-dividend date
May 29, 2026
P/E ratio
20.58
52-wk high
CNÂ¥173.60
52-wk low
CNÂ¥87.09
EPS
CNÂ¥7.35
Shares outstanding
1.05B
No. of employees
36K
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 months ago
WuXi AppTec Takes Legal Action Against Pentagon Over Blacklisting - Earnings Turnaround
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
About WuXi AppTec Co Ltd
CEOSteve Yang | Ge Li
Employees35.6K
FoundedDec 1, 2000
Headquarters-
SectorHealth care
Websitewuxiapptec.com.cn